Strategic partnership aims to support significant growth of the Ibuprofen product market in Brazil and is backed by Univar Solutions' state-of-the-art Solution Center in São Paulo, Brazil
Univar Solutions Brasil Ltda., a subsidiary of Univar Solutions, a leading global solutions provider to users of specialty ingredients and chemicals, today announced a distribution agreement with SI Group for Ibuprofen, an active pharmaceutical ingredient (API) used to produce ibuprofen drugs for the pharmaceutical market.
"Our strategic relationship with SI Group provides customers in Brazil access to a robust portfolio of innovative specialty ingredients and supply products in significant demand in the Brazilian market. We're proud to team up with a supplier who is also passionate about working at the intersection of science and technology to deliver products that help keep communities healthy and safe," said James Peterson, global vice president of pharmaceutical ingredients for Univar Solutions.
"Univar Solutions proudly serves pharmaceutical manufacturers and formulators focused on delivering advanced, science-based pharmaceutical solutions, offering the ingredients they seek for critically important health care products," said Jorge Buckup, president of Latin America for Univar Solutions. "Together with SI Group, we're better able to help customers formulate next-generation products, work to improve time to market, and achieve sustainable solutions through ingredients and innovations."
"SI Group is thrilled to grow our partnership with Univar Solutions, a global leader in ingredient and specialty distribution with deep expertise and a reliable, resilient network and supply chain solutions," said Cathryn D. Estes, senior director of pharmaceuticals and global distribution for SI Group. "Together, we can leverage our ingredients and services and bring our Brazilian customers the ingredients and products they need to grow and serve their markets."
Subscribe To Our Newsletter & Stay Updated